Calamos Advisors LLC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 44 filers reported holding HAEMONETICS CORP MASS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$255,245
+1.3%
294,0000.0%0.00%0.0%
Q2 2023$251,923
-91.2%
294,000
-91.2%
0.00%
-92.9%
Q1 2023$2,859,617
-58.9%
3,359,000
-59.8%
0.01%
-57.6%
Q4 2022$6,963,047
+4.3%
8,359,0000.0%0.03%
+6.5%
Q3 2022$6,674,000
+0.8%
8,359,0000.0%0.03%
+6.9%
Q2 2022$6,622,000
-5.9%
8,359,0000.0%0.03%
+11.5%
Q1 2022$7,037,0008,359,0000.03%
Other shareholders
HAEMONETICS CORP MASS shareholders Q2 2022
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders